BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 23728112)

  • 1. Pelvic fractures associated with long-term bisphosphonate therapy - case report.
    Patel V; Graves L; Lukert B
    J Musculoskelet Neuronal Interact; 2013 Jun; 13(2):251-4. PubMed ID: 23728112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.
    Miller PD; McCarthy EF
    Semin Arthritis Rheum; 2015 Apr; 44(5):477-482. PubMed ID: 25312241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonate long-term treatment related bilateral subtrochanteric femoral fracture. Can teriparatide be useful?
    Tarazona-Santabalbina FJ; Aguilella-Fernández L
    Aging Clin Exp Res; 2013 Oct; 25(5):605-9. PubMed ID: 24026625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual mid-shaft fractures during long-term bisphosphonate therapy.
    Odvina CV; Levy S; Rao S; Zerwekh JE; Rao DS
    Clin Endocrinol (Oxf); 2010 Feb; 72(2):161-8. PubMed ID: 19302584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical fracture of the tibial diaphysis associated with bisphosphonate therapy: a case report.
    Bissonnette L; April PM; Dumais R; Boire G; Roux S
    Bone; 2013 Oct; 56(2):406-9. PubMed ID: 23871749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report.
    Huang HT; Kang L; Huang PJ; Fu YC; Lin SY; Hsieh CH; Chen JC; Cheng YM; Chen CH
    Menopause; 2012 Dec; 19(12):1360-3. PubMed ID: 22968250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atraumatic bilateral femur fracture in long-term bisphosphonate use.
    Goddard MS; Reid KR; Johnston JC; Khanuja HS
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur.
    Black DM; Kelly MP; Genant HK; Palermo L; Eastell R; Bucci-Rechtweg C; Cauley J; Leung PC; Boonen S; Santora A; de Papp A; Bauer DC; ;
    N Engl J Med; 2010 May; 362(19):1761-71. PubMed ID: 20335571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual subtrochanteric femoral insufficiency fractures associated with the prolonged use of alendronate and risedronate: a report of two cases.
    Angthong C; Angthong W
    J Med Assoc Thai; 2011 Dec; 94 Suppl 7():S214-20. PubMed ID: 22619933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
    Ng YH; Gino PD; Lingaraj K; Das De S
    Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
    Park KT; Lee KB
    Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilateral distal fibula fractures in a woman on long-term bisphosphonate therapy.
    Murray JC; Audet MC; Bédard M; Michou L
    Osteoporos Int; 2016 Feb; 27(2):833-6. PubMed ID: 26556740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare case of a bisphosphonate-induced peri-prosthetic femoral fracture.
    Cross MB; Nam D; van der Meulen MC; Bostrom MP
    J Bone Joint Surg Br; 2012 Jul; 94(7):994-7. PubMed ID: 22733959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
    Schneider JP
    Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical fractures as a potential complication of long-term bisphosphonate therapy.
    Sellmeyer DE
    JAMA; 2010 Oct; 304(13):1480-4. PubMed ID: 20924014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teriparatide treatment in an adult patient with hypophosphatasia exposed to bisphosphonate and revealed by bilateral atypical fractures.
    Righetti M; Wach J; Desmarchelier R; Coury F
    Joint Bone Spine; 2018 May; 85(3):365-367. PubMed ID: 29246529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy.
    Capeci CM; Tejwani NC
    J Bone Joint Surg Am; 2009 Nov; 91(11):2556-61. PubMed ID: 19884427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
    Grady MK; Watson JT; Cannada LK
    Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of bisphosphonate-related atypical fracture retrospectively observed with DXA scanning.
    Ahlman MA; Rissing MS; Gordon L
    J Bone Miner Res; 2012 Feb; 27(2):496-8. PubMed ID: 22006725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
    Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
    J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.